Drug resistance pattern in multidrug resistance pulmonary tuberculosis patients

Journal of the College of Physicians and Surgeons Pakistan

Volumn 20, Issue 4, 2010, Pages 262-265

  Rao, Nisar Ahmed ^a   Irfan, Muhammad ^b   Soomro, Mir Muhammad ^a   Mehfooz, Zeeshan ^a  

^a Ojha Institute of Chest Diseases   (Pakistan)

^b AGA KHAN UNIVERSITY HOSPITAL   (Pakistan)

Author keywords

Capreomycin; Multidrug resistance; Mycobacterium tuberculosis; Resistance pattern

Indexed keywords

AMIKACIN; CAPREOMYCIN; CIPROFLOXACIN; CYCLOSERINE; ETHAMBUTOL; ETHIONAMIDE; ISONIAZID; KANAMYCIN; OFLOXACIN; PYRAZINAMIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; STREPTOMYCIN;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATE; CONTROLLED STUDY; FEMALE; HUMAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS;

ADULT; ANTITUBERCULAR AGENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ETHAMBUTOL; ETHIONAMIDE; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; PAKISTAN; PYRAZINAMIDE; RETROSPECTIVE STUDIES; RISK FACTORS; SPUTUM; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY;

EID: 77952309462     PISSN: 1022386X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Frieden TR, Munsiff SS. The DOTS strategy for controlling the global tuberculosis epidemic. Clin Chest Med 2005; 26:197-205. (Pubitemid 40503254)
2. Lambregts-van Weezenbeek CS, Veen J. Control of drug-resistant tuberculosis. Tuber Lung Dis 1995; 76:455-459
3. World Health Organization. The global project on anti-tuberculosis drugs resistance surveillance: 1994-1997. Geneva: WHO; 1997.
4. WHO report. Pakistan: global tuberculosis control surveillance, planning, financing. WHO; 2009.
5. Vestal AL. Procedures for isolation and identification of Mycobacterium. Atlanta: Centers for Disease Control and Prevention; 1975.
6. Kent PT, Kubica GP. Public health mycobacteriology: guide for the level-III laboratory. Atlanta: US Department of Health and Human Services, Centers for Disease Control; 1985.
7. Koneman EW, Allen SD, Janda WM, Schereckenberger PC, Winn WC. Color atlas and text book of diagnostic microbiology. 5th ed. Philadelpheia: Lippincott Williams & Wilkins; 1997.
8. National Committee for Clinical Laboratory Standards. Susceptibility testing of mycobacteria, nocardia and other aerobic actinomycetes, 2000: tentative standard. 2nd ed. Wayne (PA): National Committee for Clinical Laboratory Standards; 2000.
9. World Health Organization. Anti-tuberculosis drug resistance in the world: the WHO/IUATLD global project on anti-tuberculosis drug resistance surveillance. Geneva: World Health Organization; 1997.
10. The World Health Organization. International union against tuberculosis and lung disease (WHO/UNION) global project on anti-tuberculosis drug resistance surveillance, 2002-2007. Geneva: WHO; 2008.
11. Butt T, Ahmed RN, Kazmi SY, Rafi N. Multi-drug resistant tuberculosis in Northern Pakistan. J Pak Med Assoc 2004; 54:469-472 (Pubitemid 39388211)
12. Rasul S, Shabbir I, Iqbal R, Haq M, Khan S, Saeed MS, et al. Trends in multidrug resistant tuberculosis. Pak J Chest Med 2001; 7:21-28
13. Khan J, Islam N, Ajanee N, Jafri W. Drug resistance of Mycobacterium tuberculosis in Karachi, Pakistan. Trop Doct 1993; 23:13-14 (Pubitemid 23026760)
14. Karamat KA, Rafi S, Abbasi SA. Drug resistance Mycobacterium tuberculosis: a four years experience. J Pak Med Assoc 1999; 49:262-265 (Pubitemid 30085911)
15. Almani SA, Memon NM, Qureshi A. Drug-resistant tuberculosis in Sindh. J Coll Physicians Surg Pak 2002; 12:136-139
16. Masood Ul Haq, Awan SR, Khan S, Saeed S, Iqbal R, Iffat S, et al. Sensitivity pattern of Mycobacterium tuberculosis at Lahore, Pakistan. Ann KE Med Coll 2002; 8:190-193
17. Akhtar S, Haidri FR, Memon A. Drug resistance to tuberculosis in a tertiary care setting in Karachi. J Pak Med Assoc 2007; 57:282-284 (Pubitemid 351251100)
18. Irfan S, Hassan Q, Hasan R. Assessment of resistance in multidrug resistant tuberculosis patients. J Pak Med Assoc 2006; 56:397-400. (Pubitemid 46768860)
19. Hooper D. Quinolones. In: Mandell GL, Bennett JE, Dolin R, editors. Mandell, Douglas, and Bennett's principles and practice of infectious diseases. 5th ed. Philadelphia: Churchill Livingstone; 2000.p. 404-423.
20. Chan ED, Laurel V, Strand MJ, Chan JF, Huynh ML, Goble M, et al. Treatment and outcome analysis of 205 patients with multidrug-resistant tuberculosis. Am J Respir Crit Care Med 2004; 169:1103-9. Epub 2004 Jan 23.
21. Comment in: Am J Respir Crit Care Med 2004; 170:920-921
22. Barnes PF. The influence of epidemiologic factors on drug resistance rates in tuberculosis. Am Rev Respir Dis 1987; 136:325-328
23. Zialluah, Anila B, Javaid A. Pattern of drug resistance in pulmonary TB patient in NWFP. Pak J Chest Med 2006; 12:11-16.
24. National Guidelines for TB control in Pakistan. 2nd ed. Islamabad: National TB Control Programme; 1997.
25. Lu P, Lee Y, Peng C, Tsai J, Chen Y, Hwang K, et al. The decline of high drug resistance rate of pulmonary Mycobacterium tuberculosis isolates from a southern Taiwan medical centre, 1996-2000. Int J Antimicrobiol Agents 2003; 21:239-243
26. Masroor M, Ahmed I, Qamar R, Imran K, Aurangzeb, Tanveer, et al. Prevalence and pattern of resistance to anti-tuberculosis drugs in our community. Pak J Chest Med 2007; 13:21-30.